A citation-based method for searching scientific literature

F Rozet, C Hennequin, J-B Beauval, P Beuzeboc, L Cormier, G Fromont-Hankard, P Mongiat-Artus, G Ploussard, R Mathieu, L Brureau, A Ouzzane, D Azria, I Brenot-Rossi, G Cancel-Tassin, O Cussenot, X Rebillard, T Lebret, M Soulié, R Renard Penna, A Méjean. Prog Urol 2018
Times Cited: 22







List of co-cited articles
59 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
A V D'Amico, R Whittington, S B Malkowicz, D Schultz, K Blank, G A Broderick, J E Tomaszewski, A A Renshaw, I Kaplan, C J Beard,[...]. JAMA 1998
27

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, Erik Briers, Marcus G Cumberbatch, Maria De Santis, Nicola Fossati, Tobias Gross, Ann M Henry, Steven Joniau,[...]. Eur Urol 2017
27

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
Veeru Kasivisvanathan, Antti S Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A Mynderse, Markku H Vaarala, Alberto Briganti, Lars Budäus, Giles Hellawell, Richard G Hindley,[...]. N Engl J Med 2018
841
22

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
Olivier Rouvière, Philippe Puech, Raphaële Renard-Penna, Michel Claudon, Catherine Roy, Florence Mège-Lechevallier, Myriam Decaussin-Petrucci, Marine Dubreuil-Chambardel, Laurent Magaud, Laurent Remontet,[...]. Lancet Oncol 2019
241
22

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Matthew R Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris A Hadaschik, Julie N Graff, David Olmos, Paul N Mainwaring, Ji Youl Lee, Hiroji Uemura,[...]. N Engl J Med 2018
435
22

Enzalutamide in metastatic prostate cancer before chemotherapy.
Tomasz M Beer, Andrew J Armstrong, Dana E Rathkopf, Yohann Loriot, Cora N Sternberg, Celestia S Higano, Peter Iversen, Suman Bhattacharya, Joan Carles, Simon Chowdhury,[...]. N Engl J Med 2014
22

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
Marloes van der Leest, Erik Cornel, Bas Israël, Rianne Hendriks, Anwar R Padhani, Martijn Hoogenboom, Patrik Zamecnik, Dirk Bakker, Anglita Yanti Setiasti, Jeroen Veltman,[...]. Eur Urol 2019
189
18

[CCAFU french national guidelines 2016-2018 on prostate cancer].
F Rozet, C Hennequin, J-B Beauval, P Beuzeboc, L Cormier, G Fromont, P Mongiat-Artus, A Ouzzane, G Ploussard, D Azria,[...]. Prog Urol 2016
38
13

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
Jonathan I Epstein, Michael J Zelefsky, Daniel D Sjoberg, Joel B Nelson, Lars Egevad, Cristina Magi-Galluzzi, Andrew J Vickers, Anil V Parwani, Victor E Reuter, Samson W Fine,[...]. Eur Urol 2016
605
13

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Hashim U Ahmed, Ahmed El-Shater Bosaily, Louise C Brown, Rhian Gabe, Richard Kaplan, Mahesh K Parmar, Yolanda Collaco-Moraes, Katie Ward, Richard G Hindley, Alex Freeman,[...]. Lancet 2017
13

[CCAFU Recommendations 2013: Prostate cancer].
L Salomon, C Bastide, P Beuzeboc, L Cormier, G Fromont, C Hennequin, P Mongiat-Artus, M Peyromaure, G Ploussard, R Renard-Penna,[...]. Prog Urol 2013
55
13

Abiraterone in metastatic prostate cancer without previous chemotherapy.
Charles J Ryan, Matthew R Smith, Johann S de Bono, Arturo Molina, Christopher J Logothetis, Paul de Souza, Karim Fizazi, Paul Mainwaring, Josep M Piulats, Siobhan Ng,[...]. N Engl J Med 2013
13

Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial.
Fred Saad, David Cella, Ethan Basch, Boris A Hadaschik, Paul N Mainwaring, Stéphane Oudard, Julie N Graff, Kelly McQuarrie, Susan Li, Stacie Hudgens,[...]. Lancet Oncol 2018
53
13

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
Maha Hussain, Karim Fizazi, Fred Saad, Per Rathenborg, Neal Shore, Ubirajara Ferreira, Petro Ivashchenko, Eren Demirhan, Katharina Modelska, De Phung,[...]. N Engl J Med 2018
359
13

What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?
Pieter Julien Luc De Visschere, Leslie Naesens, Louis Libbrecht, Charles Van Praet, Nicolaas Lumen, Valérie Fonteyne, Eva Pattyn, Geert Villeirs. Eur Radiol 2016
46
9

Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.
Satoshi Washino, Tomohisa Okochi, Kimitoshi Saito, Tsuzumi Konishi, Masaru Hirai, Yutaka Kobayashi, Tomoaki Miyagawa. BJU Int 2017
132
9

Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
Jan Philipp Radtke, Manuel Wiesenfarth, Claudia Kesch, Martin T Freitag, Celine D Alt, Kamil Celik, Florian Distler, Wilfried Roth, Kathrin Wieczorek, Christian Stock,[...]. Eur Urol 2017
73
9

Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer.
Nienke L Hansen, Tristan Barrett, Claudia Kesch, Lana Pepdjonovic, David Bonekamp, Richard O'Sullivan, Florian Distler, Anne Warren, Christina Samel, Boris Hadaschik,[...]. BJU Int 2018
56
9

What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
Paul C Moldovan, Thomas Van den Broeck, Richard Sylvester, Lorenzo Marconi, Joaquim Bellmunt, Roderick C N van den Bergh, Michel Bolla, Erik Briers, Marcus G Cumberbatch, Nicola Fossati,[...]. Eur Urol 2017
171
9

ESUR prostate MR guidelines 2012.
Jelle O Barentsz, Jonathan Richenberg, Richard Clements, Peter Choyke, Sadhna Verma, Geert Villeirs, Olivier Rouviere, Vibeke Logager, Jurgen J Fütterer. Eur Radiol 2012
9

The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction.
Florian A Distler, Jan P Radtke, David Bonekamp, Claudia Kesch, Heinz-Peter Schlemmer, Kathrin Wieczorek, Marietta Kirchner, Sascha Pahernik, Markus Hohenfellner, Boris A Hadaschik. J Urol 2017
77
9

Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use.
Jelle O Barentsz, Jeffrey C Weinreb, Sadhna Verma, Harriet C Thoeny, Clare M Tempany, Faina Shtern, Anwar R Padhani, Daniel Margolis, Katarzyna J Macura, Masoom A Haider,[...]. Eur Urol 2016
284
9

Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?
Valeria Panebianco, Giovanni Barchetti, Giuseppe Simone, Maurizio Del Monte, Antonio Ciardi, Marcello Domenico Grompone, Riccardo Campa, Elena Lucia Indino, Flavio Barchetti, Alessandro Sciarra,[...]. Eur Urol 2018
72
9

Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up.
Anna Bill-Axelson, Lars Holmberg, Hans Garmo, Kimmo Taari, Christer Busch, Stig Nordling, Michael Häggman, Swen-Olof Andersson, Ove Andrén, Gunnar Steineck,[...]. N Engl J Med 2018
128
9

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.
Abdenour Nabid, Nathalie Carrier, André-Guy Martin, Jean-Paul Bahary, Céline Lemaire, Sylvie Vass, Boris Bahoric, Robert Archambault, François Vincent, Redouane Bettahar,[...]. Eur Urol 2018
62
9

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
Mack Roach, Jennifer Moughan, Colleen A F Lawton, Adam P Dicker, Kenneth L Zeitzer, Elizabeth M Gore, Young Kwok, Michael J Seider, I-Chow Hsu, Alan C Hartford,[...]. Lancet Oncol 2018
56
9

Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413.
M Roach, M DeSilvio, C Lawton, V Uhl, M Machtay, M J Seider, M Rotman, C Jones, S O Asbell, R K Valicenti,[...]. J Clin Oncol 2003
440
9

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.
Luca Incrocci, Ruud C Wortel, Wendimagegn Ghidey Alemayehu, Shafak Aluwini, Erik Schimmel, Stijn Krol, Peter-Paul van der Toorn, Hanja de Jager, Wilma Heemsbergen, Ben Heijmen,[...]. Lancet Oncol 2016
220
9

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.
Edward M Messing, Judith Manola, Jorge Yao, Maureen Kiernan, David Crawford, George Wilding, P Anthony di'SantAgnese, Donald Trump. Lancet Oncol 2006
561
9

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Nicholas D James, Johann S de Bono, Melissa R Spears, Noel W Clarke, Malcolm D Mason, David P Dearnaley, Alastair W S Ritchie, Claire L Amos, Clare Gilson, Rob J Jones,[...]. N Engl J Med 2017
676
9

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.
M Roach, C Marquez, H S Yuo, P Narayan, L Coleman, U O Nseyo, Z Navvab, P R Carroll. Int J Radiat Oncol Biol Phys 1994
290
9

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
9

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis.
A M Hövels, R A M Heesakkers, E M Adang, G J Jager, S Strum, Y L Hoogeveen, J L Severens, J O Barentsz. Clin Radiol 2008
473
9

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
Mack Roach, Gerald Hanks, Howard Thames, Paul Schellhammer, William U Shipley, Gerald H Sokol, Howard Sandler. Int J Radiat Oncol Biol Phys 2006
9



[Prostate cancer incidence and mortality trends in France from 1980 to 2011].
P Grosclaude, A Belot, L Daubisse Marliac, L Remontet, N Leone, N Bossard, M Velten. Prog Urol 2015
23
9

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
Karim Fizazi, NamPhuong Tran, Luis Fein, Nobuaki Matsubara, Alfredo Rodriguez-Antolin, Boris Y Alekseev, Mustafa Özgüroğlu, Dingwei Ye, Susan Feyerabend, Andrew Protheroe,[...]. N Engl J Med 2017
772
9

Cancer incidence and mortality in France over the 1980-2012 period: solid tumors.
F Binder-Foucard, N Bossard, P Delafosse, A Belot, A-S Woronoff, L Remontet. Rev Epidemiol Sante Publique 2014
135
9

Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.
Alberto Briganti, Felix K-H Chun, Andrea Salonia, Andrea Gallina, Giuseppe Zanni, Vincenzo Scattoni, Luc Valiquette, Patrizio Rigatti, Francesco Montorsi, Pierre I Karakiewicz. Urology 2007
119
9

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, Hao Wang, Yan Chen, Yezi Zhu, John L Silberstein, Maritza N Taylor, Benjamin L Maughan, Samuel R Denmeade,[...]. J Clin Oncol 2017
238
9

Abiraterone and increased survival in metastatic prostate cancer.
Johann S de Bono, Christopher J Logothetis, Arturo Molina, Karim Fizazi, Scott North, Luis Chu, Kim N Chi, Robert J Jones, Oscar B Goodman, Fred Saad,[...]. N Engl J Med 2011
9

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.
Rong Hu, Thomas A Dunn, Shuanzeng Wei, Sumit Isharwal, Robert W Veltri, Elizabeth Humphreys, Misop Han, Alan W Partin, Robert L Vessella, William B Isaacs,[...]. Cancer Res 2009
661
9

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
9

Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
Jeroen P Jansen, Rachael Fleurence, Beth Devine, Robbin Itzler, Annabel Barrett, Neil Hawkins, Karen Lee, Cornelis Boersma, Lieven Annemans, Joseph C Cappelleri. Value Health 2011
570
9


Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research.
James E Signorovitch, Vanja Sikirica, M Haim Erder, Jipan Xie, Mei Lu, Paul S Hodgkins, Keith A Betts, Eric Q Wu. Value Health 2012
118
9

Advanced Androgen Blockage in Nonmetastatic Castration-resistant Prostate Cancer: An Indirect Comparison of Apalutamide and Enzalutamide.
Christopher J D Wallis, Thenappan Chandrasekar, Hanan Goldberg, Laurence Klotz, Neil Fleshner, Raj Satkunasivam, Zachary Klaassen. Eur Urol Oncol 2018
13
15

Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2- advanced breast cancer.
Gabriel Tremblay, David Chandiwana, Mike Dolph, Jaclyn Hearnden, Anna Forsythe, Mauricio Monaco. Cancer Manag Res 2018
7
28



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.